What’s “The Royal Gold of Marijuana?”

Hello, Gumshoe friends! I’ve been off the grid for a little while, but it’s good to be back — and it’s nice to see the pile of hot, steaming teaser pitches that have larded up my inbox over the past couple weeks.

So… which one to look at first? I’ve had a lot of requests for an answer to Matt McCall’s “Royal Gold of Marijuana” pitch, so I guess we’ll get things going there… after all, if there’s one thing I love it’s a nice royalty investment, the best of them can become a perfect passive income stream for a lazy investor (the worst of them, not so much… but lets be open to some optimism to begin the week, shall we?)

Here’s how McCall tries to get us excited in his pitch for his new service called Early Stage Investor ($1,999/year “on sale” at the moment):

“Few chances like this will ever come along in your investing lifetime… and if you act before July 18th you could watch a small stake grow into a massive fortune.”

And he gets us on his side by admitting that looking for the next huge penny stock boom in pot is a loser’s game…

“The odds of you finding the next marijuana penny stock that goes from $1 to $30…or building a big pot business from scratch are pretty slim, and very risky.

“So I’ve got a much better idea for you…

“A third type of investment has just opened up in the red-hot marijuana markets…”

That is, of course, royalties… the notion that you pay up front for a perpetual share in something. Here’s more from McCall…

“You see, what I’m about to share with you is an incredibly rare phenomenon. It’s only occurred a small handful of times in the past few decades, in other industries….

“But on many occasions, it’s resulted in an explosion of wealth so incredible, the numbers almost seem made up:

“The first time we saw it was in 1983 when it returned early investors as much as 45,300% gains.

“The next time it happened was in 1992 when it showed early investors a whopping 297,900% gain.

“Then it happened again in 2004 for 1,700% gains.”

Then he gets more specific about the Royal Gold (RGLD) connection, which started with a failed explorer run by a guy named Stanley Dempsey… who had an oil and gas company that faltered in the early 1980s when oil prices collapsed, then switched to gold exploration, and then, after the market crash in October 1987, turned to partnering off its gold projects… which ended up being the mostly passive, royalty-receiving business that ended up working for them, much as it did for Franco-Nevada (FNV), the other early pioneer of royalty-based financing in the gold market. Here’s a bit of McCall’s spin on that story…

“You see, Dempsey took what little money he had left… and rather than spend it to have his own company explore for more gold… he offered it to other, more knowledgeable and experienced folks in the gold mining industry…so they could explore. And in return… Dempsey’s company would receive a percentage of whatever gold the mining companies found and sold… in the form of huge royalty payouts.

“In other words, his new company didn’t explore or produce gold. They didn’t own drills, or trucks, or any of the other incredibly expensive trappings of the mining business either.

“They simply paid other folks to find gold for them and took a percentage of the profits in return.”

So that’s pretty much true — though it took decades for the huge riches to build and compound, and there were certainly hiccups along the way for Royal Gold (and the other precious metals royalty companies)… but what does this have to do with marijuana?

McCall says Dempsey had a couple key strategies that made Royal Gold work…

“Dempsey knew the key to making this work was to stack the odds in his favor.

“First, he only worked with the most knowledgeable and experienced miners in the industry — in short, the guys who knew where the gold was.

“And second, he spread his capital across a wide variety of projects…

“This way he maximized the probability of finding a ‘winner’ — if even one of the mining operations he funded discovered gold, he’d receive royalty payments for years.”

Those are both “duh” strategies, of course — at least for a financier. It’s obviously key to work with companies and people who you trust, and to diversify. And certainly royalties on a few good mines make up for all the money you lost by buying royalties on properties that never had a real discovery or on mines that never got built.

Royalties are by far my favorite way to invest in mining… but compared to a lot of other industries, investing in gold mining royalties is still a very high-risk business that requires you to guess about the future not only when it comes to things no one can control (gold prices, drilling results, geological surprises) but also about management acumen in managing a massive permitting, construction and development project. That’s why these deals make a lot of money when they work out, because a lot of the time they don’t work out.

OK, so now we get into more specifics about this “Royal Gold of Marijuana” … here’s a bit of a sum-up from McCall…

“You see, the key to making a fortune in royalty companies is to get in at the very beginning… you want to be there first.

“As you’ve probably guessed, a brand-new royalty opportunity has just opened up… only this time it’s in one of the newest and fastest-growing industries in the world today…

“I’m talking, of course, about the red-hot marijuana industry.

“Right now, you have the rare opportunity to get in at the early-stages of this brand-new royalty opportunity… what I’m calling the ‘Royal Gold of Marijuana.'”

What makes gold royalties work? Mostly two things: Finding and producting more gold than was initially expected, and than was predicted in the models you used to judge the price of the royalty, which happens pretty often (there’s no financial incentive to “define” reserves beyond what is required to make the mine feasible enough to get financing, but mines often expand dramatically and produce for more than twice as long as the initial assessments predicted); or enjoying leveraged exposure to higher gold prices. You can make a lot of money either by producing gold for many years beyond the “break even” point (when the money you invested for the royalty is paid back), or by seeing the price of gold soar far higher and thereby speeding up the repayment of that initial investment and getting to those “profit” years.

That’s pretty much it — there’s no magic, and since you’re not exposed to operating costs you don’t care how profitable the mine is as long as it is profitable enough to keep operating… all you care about is whether your share of the production can be bigger than expected or continue for longer than expected, or whether the produced volume of whatever the commodity is will be more valuable because the prices in the future are higher. It looks like magic when it works well, partly because, when it comes to gold, higher prices also meant that the mines produced for longer because it was worth producing the lower grade stuff, or allowed miners to invest heavily in expanding the mines, so you got a bit of double leverage that way… but it’s not magic.

Why does McCall see riches for this royalty-style company in the marijuana space?

“… according to Business Insider 85% of marijuana consumers haven’t moved into the legal market yet.

“That means a huge underground demand is just waiting to be unleashed in the legalized world.

“Gold, on the other hand, has been around for centuries. By the time Royal Gold began mining, there was already an established market…and they still handed investors a fortune.”

Unlike gold, of course, marijuana production is not at all constrained in any physical way — it doesn’t have to be found, it just has to be grown, and with hydroponics you can build a plant in a year and produce several harvests a year soon after. Gold production does not respond nearly as quickly to increased demand, which is part of what helps prices to rise (and what has historically made gold a pretty good currency, given the naturally limited supply).

And we’re told that this market has made some huge royalty deals possible…

“Gold royalty businesses often typically receive about 2-5% of revenues from gold extracted from a mine…

“Compare that to the ‘Royal Gold of Marijuana’ which already has deals in place that deliver 30-50% of the total cannabis sales from several different growers.

“Bigger royalty deals in a much more profitable industry? Add it all up and it’s not hard to believe how this tiny marijuana company could ultimately outperform even Royal Gold’s outstanding returns.”

The flip side of that, of course, is that if things turn out to be less exciting on the income statement than a marijuana company predicts, then having 30-50% of their top line committed to a royalty company could be a major drag on the company’s operations, endangering their ability to survive a downturn. Royalties that are too big to handle and screw up the economics of the underlying business aren’t good for anyone.

But I’m putting the cart before the horse here again, that 30-50% could be a significant exaggeration… so let’s see what this company actually is, shall we?

“… these larger royalty percentages mean it has the potential to receive tens even hundreds of millions each year from several royalty partners.

“That’s a far cry from Dempsey’s most lucrative royalty stream that paid out around $10 million annually.

“Of course, the truth is, even if this marijuana royalty stock only does half as well… or even 1/4 as well as Royal Gold, it could still turn an investment of just $1,000 into $100,000 or more.”

And we’re also told that these can be very long-term royalties… which is certainly good news, it’s often after that first 5-10 years that a royalty really starts to generate dramatic profits.

“In the gold business, royalty deals typically last for the life of the gold mine… which is usually around 10-25 years.

“With cannabis, it’s a completely different story.

“As a renewable resource… it can never ‘run out.’ Because of this, the ‘Royal Gold of Marijuana’ has multiple deals set up that pay out lucrative royalty streams for up to 99 years!”

And the pitch says that these are also very good deals, with some examples:

“For example, this company has a royalty stake in what will soon become the single largest marijuana indoor grow facility on the planet.

“It’s a former KRAFT food manufacturing plant. Currently under renovation, this state-of-the-art facility will be the size of more than TEN football fields.

“With more than 600,000 square feet of grow space, it’s going to be the Madison Square Garden of the pot industry.

“When completed, this gargantuan facility will churn out more than 40,000 pounds of marijuana per year.

“And the best part? The ‘Royal Gold of Marijuana’ gets a cut of the revenue. And I’m not talking table scraps, either. They’ve negotiated a massive 50% royalty deal on all the pot produced at this facility — for — get this — up to the next 99 years!”

And sums that up…

“That means, when completed and at full production, this tiny royalty firm could rake in as much as $220 million per year for multiple decades… all from a one-time $120 million initial investment.”

And he says they’ve got lots of other deals in place as well, including one with a pharmacy chain…

“… this ‘Royal Gold of Marijuana’ has landed the deal of a lifetime — think CVS or Walgreen’s, only the Canadian version.

“In short, it’s secured the rights to the sales of high-quality medical-grade pot, with the potential to be sold in 40 pharmacies, with as many as 1,500 locations across Canada.”

So we’re getting an abundance of clues here… and I’ll throw just one more on the pile to make sure the Thinkolator has plenty to work with — the ad cites the connected leadership team as one of the reasons why marijuana companies will want to make royalty deals with this little firm:

“… the CEO of this company is a veteran of the marijuana industry…

“He’s already founded another hugely successful cannabis company, called Canopy Growth Corp (which I mentioned earlier this presentation)…

“He took that company public in 2014 for just $3 a share…

“Today, it’s the largest pot stock in the world, in terms of marijuana produced.”

McCall also throws out a couple catalysts to entice possible subscribers — one, of course, being the impending recreational legalization of marijuana in Canada, which has been on the lips of every marijuana investor for over a year now as the turning point that will bring massive fortunes (and, of course, that’s also the reason that all the big marijuana companies in Canada are investing heavily in increased production).

And the other is that their first royalty will soon start paying, so they’ll actually have some revenue to get people excited. Here’s how he puts it:

“… as early as July 20th this tiny company is looking to receive its first major royalty stream—as much as $1.7 million—is scheduled to come online, according to our more conservative estimates.

“And this is just the beginning…right after that another royalty payout is lined up.

“This one is even bigger—roughly $3 million.

“Again, when these big revenue streams start pouring in, big institutional investors could take notice and begin to pour billions into this tiny stock…”

And then next year more royalties start pouring in…

“2019 is when this company will really start to cash in on their deals. During the first half of the year, our analysis shows royalty streams of $5 million, $7.5 million, and even a big delivery of $40 million are scheduled to come in….

“All told, over the next 18 months, this tiny company is expecting to reap the benefits of over 90,000 lbs of marijuana …an amount which could exceed $90 million.”

So who is it? Well, part of the reason why it may still be somewhat “secret” is that they keep changing their dang name, but the Mighty, Mighty Thinkolator says the company being touted is Auxly Cannabis, formerly Cannabis Wheaton (XLY.V in Canada, CBWTF OTC in the US).

Auxly was started last year as a streaming company for marijuana, which is where the “Wheaton” name came in (Wheaton Precious Metals, previously Silver Wheaton, was the pioneer of the “streaming” business model, where companies were paid up front and the streaming company received a large chunk of ongoing production, usually at an ongoing price far below the current market price), but apparently this name change to Auxly is meant to emphasize the fact that they’re going beyond streaming to be “immersed in all aspects of the cannabis value chain” — so it sounds like they’ve at least hired some more MBAs to get their business gobbledygook-speak up to par.

Why is this a match? Well, the CEO and founder of Auxly, Chuck Rifici, was indeed a founder of Tweed, which later became Canopy Growth… so that’s a match. As are a couple of the specific deals, including that “single largest” grow facility in a former KRAFT plant (that’s a deal with FV Pharma, which does indeed give them 50% of all cannabis cultivation, excluding the existing cultivation, for 99 years), and the $55 million they’ve invested in ABcann to get 50% of production from a newly constructed indoor cultivation space for 99 years, starting late this year.

So I’m convinced that the Thinkolator is right on this one… but is Auxly a great investment? For that we have to look beyond the ad pitch and think for ourselves.

So far, it’s been a disappointment if you bought during the initial enthusiasm, when lots of talk about what was then Cannabis Wheaton becoming the first great royalty company in Cannabis drove the shares up for a little while in the Spring of 2017 to about $1.50, then more dramatically back in December, when the stock surged to over $2.50 (Canadian) on the impending “legalization” news that sent pretty much all Canadian pot stocks bonkers over the winter. Now it’s around $1.10, though the market cap has surged to close to C$600 million now because they’ve raised so much money (the share count has gone from about 50 million when they were first becoming a “streaming company” early in 2017, to about 566 million shares outstanding now according to the Toronto Exchange numbers).

And that, really, was my primary concern about Auxly when I first started looking at them a little over a year ago. I love royalty companies and streaming companies, the business model takes a lot of the risk off the table and provides for possible long-tail returns that can be phenomenal… but they are also primarily financing companies, which means that they have to first raise the money to fund these deals they’re making, and should be valued at something like the amount they’ve invested in those deals. There can be valued added by a great management team, and it’s certainly possible for a financier to make great deals that are worth twice what they paid — but if you’re assuming the company is worth more than twice what they’ve invested in future income streams, then you’re making a huge leap of faith.

Of course, leaps of faith are nothing strange in the marijuana space, which has been fighting it out with the blockchain sector when it comes to attracting speculative capital and providing bubblicious daydreams to individual investors. The folks who dreamed about the next big gold mine a decade ago are now dreaming about the next huge cannabis brand.

Here’s what I wrote to the Irregulars about Cannabis Wheaton when it was facing a bit of selling pressure last Summer…

“The streaming deals they have so far look terrible, honestly — the ones I’ve looked at where they’ve provided some specifics are based not on current economics, but on some hypothetical world where prices rise dramatically for legal marijuana in Canada. That might come, but this is going to be a regulated market that might even have strong price controls, and I suspect a bank wouldn’t lend based on those estimates… a streaming company trying to expand quickly apparently will, and perhaps that’s why the streaming company hasn’t raised the $500 million they need to fulfill their end of the streaming deals they’ve made… and, it seems, is having some trouble raising even a tenth of that amount. Which, in turn, could mean that some of their streaming deals won’t close, because the deals that I saw described in detail were contingent on Cannabis Wheaton raising money.

“I do kind of hope that this one hits a rational price as disenchantment continues, and they did bring in a new executive this week, presumably with some hope of righting the ship and restoring some credibility, but we’ll see — it’s quite possible that they missed their chance now. If you intend to build a long-term successful business, it’s short-sighted to be raising this money with junky convertible debt and warrants when there’s a lot of interest in marijuana equities, they could perhaps have set themselves up for a much healthier business if they had just sold a big slug of equity right away and kept expectations a little more in check… but, of course, that would have driven the price down a bit more, at least in the short term, and it seems to me that many of the marijuana market participants who are starting or listing companies in the public markets seem to be quite enthusiastic about getting their windfall profits quick before the story or sentiment changes. That’s probably a word to the wise for us all: Investors can obsess over share prices and have wild mood swings, but when companies themselves are focused on the short term stock price movement instead of on building a sustainable business, things can get ugly quickly.”

So if you had listened to me back then, you would have missed that 150%+ run into late December, but also avoided the belly ache of the 60%+ drop since the highs early this year. The price per share of Auxly is now within about 5% of where it was back in early June of 2017, when I wrote those words, though the market cap has risen 300% and they’ve also added about $90 million of debt.

But that’s all in the past… what’s the story now? Is Auxly now appealing after this long drop in 2018?

It’s certainly not an unknown stock, it has been profiled by lots of the free pundits out there (including the Motley Fool here), and it’s been teased a few times by various newsletters (including Jimmy Mengel starting last year, and the Casey folks this year).

They do have more deals now — you can see some of them outlined on their “Partners” page here, though they don’t talk much about what they paid for these deals or what their ongoing obligations are (my concern a year ago was that Auxly, then Cannabis Wheaton, was being valued as if they had already paid for the deals they had made, when in reality they hadn’t even raised the money to pay for those deals yet). The total production is indeed impressive, more than 200,000kg of marijuana is due to Auxly from its partners when all the operators are producing at full tilt, though that could be many years into the future.

As of last quarter, Auxly reported that they have sufficient capital (about $200 million) to cover their obligations over the next twelve months — so that’s good (the money came from their accelerated warrant conversion process once the stock hit its highs over the winter, plus $100 million in convertible debt sold this year). That means these deals that are currently in progress, the growing facilities being built, etc., can actually be paid for… a good starting point.

The share count will likely continue to balloon, even if they don’t raise more money, because they’ve been aggressively using their shares to acquire more companies — including several relatively small acquisitions made just since the end of the March quarter, which could serve to dilute the impact of any near-term cash flow from their streaming deals that are expected to start generating revenue… so that’s a concern, as is their continuing predilection to act like a junior mining company and issue lots of warrants and convertible debt instead of plain old equity.

There is actually one sell-side analyst with estimates out for Auxly, predicting two cents of earnings per share in 2019 and 18 cents in 2020, based on the dramatic rampup from $7 million in revenue this year to $570 million in 2020. We shouldn’t base much on the estimates of a single analyst, particularly because it’s probably a company that’s doing business with Auxly (there’s not much other reason for an analyst to cover a company this small), but it’s a start.

So I am forced to stick with accounting on this one, given my lack of interest in reading the details of each of the deals Auxly has made with royalty or other partners, and the accounting says that as of March they had $206 million in cash, $14 million in product receivables (marijuana they’ll be paid in exchange for money lent), $19 million in long term investments, $4 million in property, plant and equipment, and $30 million in “intangible assets”. That totals up to C$273 million, not including another $4.5 million in “goodwill,” which is what they’ve paid for some assets in excess of their value.

They’ve made a few deals since then, but they don’t change the makeup of the company dramatically — so that’s what the accountants believe that Auxly is worth, they have about $200 million in cash and they’ve bought stuff that’s worth about $70 million so far. We can argue about whether they’re valuing those assets fairly or not, but since it was all acquired during the past year I assume there shouldn’t be major differences between what they paid and what the assets are worth — these aren’t hidden assets that have been depreciated over the years, or brand names that are worth far more than the price paid, these are business deals that they made in a competitive environment.

So my base case assumption, having not scoured through the details recently but having been generally unimpressed with the early streaming deals last year, is that a well-connected management team is worth a premium price when managing deals in a nascent sector like this — but since it’s a commodity business still, without clear brand leadership and without any clarity on regulatory pricing, I wouldn’t want to pay more than a 100% premium.

I don’t like the idea of betting on higher marijuana prices, because I don’t think there’s much to be gained by betting on the price per gram of marijuana rising dramatically over the next couple years — part of the reason for legalization is to squeeze out the black market, and if prices are much higher than the $7-10 per gram that Canadians currently pay the black market can undercut the regulated and legal market… particularly since it would be almost impossible to identify whether a person is carrying legal or illegal marijuana.

The continued existence of a large global black market and the massive increase in regulated and legal production in Canada will do plenty to keep prices in check, I think, and I suspect that Canada will have price controls that keep the legal stuff pretty cheap — though once edibles and drinks are legalized, anticipated next year, it will get a lot tougher to control prices as the variety of products explodes. I could be wrong on that, but that’s my base assumption that gives me caution about Canadian marijuana stocks — it will be a booming market in terms of revenue and production, but I’m not sure whether it will boom in terms of profits because I think per-gram pricing will probably fall.

So in that environment, with Auxly’s odd web of distribution and production deals and partnerships and streaming/royalty agreements, I’d be willing to consider paying a price that assumes their deals are worth twice what they paid for them. To get to that number we double all the assets other than cash, and add in the cash, and that gets us to just under C$350 million. That’s the price where I’d start thinking that I can invest in Auxly without making wildly optimistic assumptions — perhaps if I knew the deals or the marketplace better in Canada I’d be willing to pay more, I don’t know, but I don’t find a C$566 million valuation all that compelling.

That doesn’t mean the stock won’t rise, of course — it is a great business model in the abstract, though we will have to wait to see how it plays out given Auxly’s costs and assumptions (the company is not just a passive partner, and these are not primarily passive royalties but are mostly streaming deals that give them a share of production at a cost — either a fixed cost, or a joint venture obligation to help with marketing, development, distribution or other expenses… more like joint venture deals).

And it’s certainly possible that the stock will rise again in a manic spike when marijuana headlines about the first legal recreational sales hit newspapers… I just don’t want to speculate on that happening, so I’ll hang back and will wait to see if this risky but interesting stock gets cheap enough to consider buying. I love royalties, and I have some general appreciation for the way Auxly is developing a large financing operation that’s sort of like a royalty business for cannabis, but I don’t like the price investors are asking me to pay for the shares right now.

I must close by also stating that I could just be a boring old fuddy-duddy, and I have problems with the valuations of pretty much all the marijuana stocks I’ve looked at — so perhaps I’ll just miss the fun, and I can live with that. So I’ll turn it back over to you, dear friends and readers: Think I’m missing out? See a great future ahead for Auxly (or your own favorite marijuana stock)? Let us know with a comment below.

Disclosure: I own shares of Franco-Nevada, which is mentioned above. I don’t own any of the other stocks mentioned, and will not trade in any covered stock for at least three days after publication, per Stock Gumshoe’s trading rules.


Are you getting our free Daily Update "reveal" emails?
If not, just click here...



Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

Share your thoughts...

53 Comments on "What’s “The Royal Gold of Marijuana?”"

Notify of
avatar

This site uses Akismet to reduce spam. Learn how your comment data is processed.

MFC
Guest
0

I just looked up the price of CBWTF. It is .83. What is a reasonable price to buy?

CryptoInvestor
Irregular
32

I’m a believer in Auxly. I like it up to about 1.25. Stock is coming out of a nice bottoming formation – not a perfect cup ‘n handle, but a solid one. I think they could take out the old 52 week high of around 2.25 in the next 12 months. Longer term, it’s hard to say, but we’re in the top of the 2nd inning in this nascent space. I added more to my position at 0.90 just recently.

Add a Topic
5706
vivian lewis
Guest
0
I just sent Gumshoe an update on Benitec Biopharma, the stock I recommended which was dissed by Dr. KS on this site. It doubled today so I thought maybe I can boast a bit. Is the anonymous doctor still writing here? I cannot tell. While on the subject of drugs I learned about marijuana when I was in high school here in NYC, calss of 1958 (we just celebrated our 60th reunion where no pot was scented.) All you folks from the heartland are only beginning to catch up with me. The next time I ran into freely available pot… Read more »
Add a Topic
5971
Add a Topic
4091
jeremiahberndt
Irregular
62

That guys doesn’t write here anymore

marora2017
Irregular
5

I have owned the stock and its value has declined so far since their name change. It will be interesting to see how it performs after October 17, 2018. I see potential in the concept; thats why I am staying in and will buy more to offset my initial buy in price.

Add a Topic
5971
Joan White, retired Registered Investment Advisoor
Guest
0
Joan White, retired Registered Investment Advisoor

Thanks for your observations, Travis. Much appreciated.
Methinks that I would prefer to invest in companies that process or sell materials that are necessary

steveflick
Irregular
334
Thanks Travis, I am one of the folks that asked about this teaser. I think you are spot on about Auxly/Wheaton; and do not plan on investing in them, nor Matt McCall’s new service. I am 65, retired, and can not wait years for royalties. I am invested, small $2k speculative each, in 14 cannabis grow or cannabis industry related companies. Readers – don’t be concerned about McCall’s July 18 deadline – public held companies stock prices will probably be sideways all summer, and hopefully start rising after Labor Day, as Canada’s October 17th legalization date approaches …..giving you time… Read more »
Add a Topic
5971
Derick
Guest
0

What are some of the cannabis stocks you’re involved in?

steveflick
Irregular
334
I started with Travis’ talked about IIPR Innovative Industries REIT and IIPR.PA Innovative Industries preferred. Mid-April and June 1 I added CGC Canopy Growth CNTTF CannTrust Holdings CRON Cronos Group GTBIF Green Thumb Industries GWPH GW Pharmaceuticals HYDDF Hydropothecary KHRNF Kihron Life Sciences LXRP Lexaria MMNFF Medmen Enterprises OGRMF Organigram SNNVF Sunniva TGODF The Green Organic Dutchman Between mid April and June 1 I held & sold Aphria, Aurora & MedReLeaf. I am awaiting Acreage Holdings, of U.S., to go public. As part of your due diligence, I suggest 3 weekly (free) enewsletters. 1. Let’s Toke Business Newsletter by Ted… Read more »
Add a Topic
4091
CryptoInvestor
Irregular
32
I researched heavily and put quite a bit of capital to work. I own about 18 names, some spec plays, some takeout plays, and some picks and shovels (that I don’t really recommend). Most of my allocation is in the top 8. I’ll try not to duplicate what the other poster provided. The Big Boys are Canopy CGC, Aurora ACBDD, and Aphria APHQF. Canopy is my biggest position. I think Aurora and Aphria are still buys right here (Sept, 2018). I wouldn’t touch Tilray TLRY here. It’s in outer space, and likely due to US listing. Aurora and Aphria are… Read more »
Add a Topic
5087
Add a Topic
5706
Add a Topic
5448
gary
Guest
0
There is a new marijuana stock that trades on the CSE exchange that has the symbol crop. c r o p. It acts as a royalty stock as well as a REIT in a sense. I’m wondering if anyone has looked at this stock and may be able to comment on it. I own a small amount from the initial public offering, and am not sure how this will turn out. It does seem to have garnered a fair bit of Interest based on the volume that it has been trading recently. Had a huge short interest that has made… Read more »
Add a Topic
4091
Add a Topic
5971
Add a Topic
5971
Oregon don
Guest
0

the 50 day av dropped below the 200 day average in march and it has been on a down road path since. closing price on 20/7/18 is $32.33 US

chris campion
Guest
0

It may also be HUGE
XLY invested $55 Mill.??

green2017
Irregular
16
When I stopped by Wheaton Silver’s booth at the pdac conference last march they said that their lawyers were taking action to force a name change for Cannabis Wheaton. Another thing to consider; a lot of investors don’t realize that the building of most of the growing facilities has been at inflated prices. As a greenhouse owner (not in the cannabis business… sigh) I have a good idea about what the facilities should cost and I believe most facilities have been built for a 20 to 50 percent premium on the materials used. Understandable given the circumstances but it means… Read more »
mypanama2
Irregular
6

The marijuana stocks that have made the most money for me are Canopy Growth and Medrelief.

Add a Topic
4091
srpsloan
Irregular
5

mypanama2 would you buy Canopy Growth and / or Medrelief today?

Suzanne Lucas
Guest
0

My investment newsletter says to hold MedRelief (neither buy nor sell) and buy Canopy Growth up to $50/share. It is now $29.61, so buy.

CryptoInvestor
Irregular
32

MedReleaf was purchased by Aurora for a substantial premium. That was my biggest holding, but now Canopy is, followed by Aurora, Aphria, Organigram, Liberty Health Science, Auxly.

I personally think Canopy will continue to go up more slowly over time. Some think it’s due for a big pullback, but I think there will be buyers below 50. I think Aurora and Aphria, Aurora, Liberty, and Auxly are buys right here.

Add a Topic
5087
Add a Topic
5706
jpeters98
Irregular
27

I have never smoked weed, but I rode Canopy Growth(WEED TSX) from $8 CDN to $43 . Now that was a HIGH!

warderwill
Irregular
12

When rejecting most other companies you simply pass. This one you want a 40% further discount yet in the write up state maybe a 100% premium. So no comment on the fact they have $200M+ and money to invest? Admittedly no interest in reading about their deals? I’m for the first time disappointed in a Gumshoe response, maybe I’m a sore loser, but at least not an old fuddy with a bias

Suzanne Lucas
Guest
0

Since October 2017, I am up 9% on Auxly Cannabis. I know that is not a lot, but I think it will definitely be a winner in the future.

Sargam
Guest
0

warderwill – you’re a non-paying Irregular, like me. First, give a thought to all the work that Gumshoe put into writing this article. Second, before you criticize, have the decency to do a tiny little bit of thinking. Less than 1% of what Gumshoe did. Read the article. His 40% price discount takes into account the cash and asset position (which Co. admits they overpaid). Third, don’t call Gumshoe names. It suggests that you know better, which insults everyone, including yourself.

Oscar
Guest
0

The keyword is that it is a financial company with no product to sell. They are as good as their money is but otherwise it is just an office with a bank account. To value them 2x the value of the deals is really the ceiling here – already a stretch in real life. This is like making tea twice from the same bag, you may as well invest in the underlying companies that have factories and products to sell.

charles l harowitz jr
Guest
0
charles l harowitz jr

one of the mj stocks with no revenue, many much better

Peter Z
Guest
0
https://www.angelnexus.com/o/web/165728 Hello, did anyone notice that the above company is pumping In Med Pharmaceuticals / IMLFF, claiming it can climb 63 fold in value from here ? Might be a much better deal here than Auxley. They are also asking new subscribers to pay $1,999 for a subscription, before they will tell people that the company pumped is IMLFF. They are making some claims that InMed has found a component that can cure breast cancer although breast cancer is not very high on their list of priorities. IMLFF is the company that claims they can synthetically reproduce the 80 to… Read more »
Add a Topic
372
Add a Topic
3359
Add a Topic
3397
Lulu
Guest
0

and I do believe another Gummie suggested that our Prime minister had his mitts i this one but I have heard no such comments since that one time on another thread.

anastasia
Irregular
12

First of all, let us have a look at Chuck Rifici’s corporative surrounding (ousted from Canopy), his strange taste for the red (web page, Canada Liberal Party…), and where does he go strategicaly from Nesta Holding Co? adding to the risk?

Add a Topic
1515
mccomasjr
Member
2

my brokerage does not allow me to trade stocks ending in
” F “;which probably Canadian or foreign. Any recommendations would be greatly appreciated. TYVM

steveflick
Guest
0

Travis as always is spot on. I trade at Fidelity. If an OTC fund is newly listed, there may be an additional international trading fee, $50 with Canada listed funds.

Add a Topic
3600
Add a Topic
1515
steveflick
Irregular
334

oops, forgot to sign in – Travis as always is spot on. I trade at Fidelity. Some new listed OTC funds also incur an international trading fee, $50 for Canadian listed funds.

Add a Topic
3600
Suzanne Lucas
Guest
0

I trade on my own with Charles Schwab. Their fee is only $4.95 and they have excellent customer service.

saint stephen
Irregular
188

Marijuana is having growing pains. For one thing 85% of the market is still underground, and the users are reluctant to pay high prices for taxes and fees when they can da kine for less from their old dealers or grow their own. I believe these things will work out in time, but it’s not going to be a gold rush for awhile.

Add a Topic
4091
Add a Topic
372
Add a Topic
210
william kobin
Guest
0

The following stock might be a real big winner-Has anyone here heard anything about it besides me? Cannabix Technologies -BLOZF The Product-a handheld marijuana
detecter in the prototype testing stage.Every police dept. Canada & Us is a potential account. The item itself is very difficult technically to miniaturize and the obvious need is already manifest.

Add a Topic
5971
Add a Topic
4091
Add a Topic
1515
aegetswil
Irregular
0

Too late? – check this out with google translate: https://www.nzz.ch/zuerich/aktuell/zuercher-polizei-fuehrt-schnelltest-fuer-cannabis-definitiv-ein-ld.1340487
Such a product is already in use here in Switzerland. And I bet that other police Departments around the world know about this.

Carl Davis
Guest
0

Travis
Great Synopsis of Auxly! I currently own (CRON) based primarily upon their current
Worldwide Distribution Contracts and I would Certainly Appreciate your Personal
Analyses on this company’s prospects and projections over the next 3-5 years?
Thanks Much.

Add a Topic
7
roberthebel
Irregular
85
What’s up mr gumshoe!! I think there is a little confusion when it comes to Wheaton/auxly When they first came on the scene it was a complete mess. The long and the short of it is that employees of co-lead agents Eight Capital and Cannacord Genuity owned approximately 8% of Cannabis Wheaton, which drew red flags. Cannabis Wheaton “mutually agreed to terminate” the agreements with both companies. Eight Capital removed and replaced its CEO Mark Attanasio over the debacle. This obviously had me concerned. But thankfully, the company was able to engage Mackie Research Capital Corp. to act as lead… Read more »
Add a Topic
899
Add a Topic
5971
Add a Topic
5971
Astrovel
Guest
0

Robert, I would dearly love to know your opinion on the various things you posted on but your post is SO DIFFICULT to read with 5 sentences all looped together into one. You need to stop and put some periods in between thoughts, my love. Just take a breath in between thoughts. Just a polite request for the future.

johnpeds
Irregular
0
I guess I’m susceptible to the notion that there’ll be a lot of money flowing into the MJ business and wonder if there is someway I can get some of it. Brian Hicks the founder and president of Angel Publishing is hyping a mystery stock that he claims has been identified by BRITON RYLE (and he hypes the track record of Briton), a REIT that specializes in renting land to growers of MJ. “It provides one thing and one thing only: the land for companies like these to build their grow facilities and botanical laboratories.The demand for real estate is… Read more »
Add a Topic
80
Add a Topic
1362
Add a Topic
5971
johnjones1
Member
5

CROP INFRASTRUCTURE CORP – This one is fairly new and is essentially a REIT that leases their properties to producers.

CROP:CANADIAN SECURITIES EXCHANGE – CROP (ticker on the CSE) CRXPF on the OTC PINK

The REIT structure seems like a greaat business model that might reduce risk in this sector. Not sure about the company in question, but would welcome any opinions and/or analysis of CROP and similar type MJ stocks that are in the business of leasing real estate to producers.

Add a Topic
409
oregon don
Guest
0

I am ahead on I bought on 10/26/17 IIPR

johnjones1
Member
5

I subscribed. 6 month money back guarantee for $49.

The company is IIPR – Comments?

Oregon don
Guest
0

making me a profit

steveflick
Irregular
334

johnpeds and johnjonesI, Mr Gumshoe himself, Travis, has talked about IIPR in past articles, simply use Search field. He is positive

Add a Topic
4091
Add a Topic
5951
Peter
Guest
0

Still trying to see what opinion people have of IMLFF- InMed Pharmaceuticals, the one that claims they can synthetically produce many/ most of the 80-90 medicinal components of MJ.
This newsletter claims it can climb 63- fold in value from here, but from info on message boards it seems the process will take a lot longer than what was previously thought.
https://www.angelnexus.com/o/web/165728

bobarino
Irregular
1

All of your comments very much appreciated. I have been trying to make sense of this space. Reading about regulatory and banking issues. Lots of generalities but here I found some actual companies and newsletters.
Thank you all!

Carolyn
Guest
0

I’d this real

CryptoInvestor
Irregular
32
Similar comment as before. Auxly is executing, and they are an interesting and unique company in the Canada cannabis space. They have quite a few streaming deals for MJ production, and have built up an interesting vertically integrated “ecosystem” of partners. They seem financially savvy and do not overpay for their acquisitions (like many others in the space) and seem to have access to quite a bit of capital. This allows them quite a bit of flexibility to make deals and they aren’t really in direct competition with the 3 big boys. I think they will get included in many… Read more »
Add a Topic
5706
Add a Topic
4091
steveflick
Irregular
334
steveflick